Final Evidence Report and Meeting Summary

PDF cover

Interventions for Management of CHF: Final Report

This report examines the comparative effectiveness and value of two interventions for the management of congestive heart failure (CHF): the CardioMEMS™ HF System (St. Jude Medical) and Entresto™ (Novartis). It includes a systematic review of the published evidence, as well as an economic analysis that examines cost-effectiveness and budget impact of the two interventions. The results of these analyses are used to produce an ICER value-based price benchmark for each intervention; these are prices that reflect the magnitude of estimated improvements in long-term patient outcomes and thresholds for new drug and device costs that do not exceed growth in the overall national economy.


View All Materials on this Topic or Go Back to View More Materials